MedTrace Logo

Impact of Gum Acacia on Chronic Kidney Disease Patients

NCT05599399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-06-22

No results posted yet for this study

Summary

The aim of the study is to evaluate the impact of gum acacia on serum levels of protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate).In addition to the evaluation of its effect on metabolic profile and disease progression in chronic kidney disease patients.

Conditions

  • Chronic Kidney Diseases

Interventions

DIETARY_SUPPLEMENT

Gum acacia

25 grams of gum acacia powder is administered on daily-basis

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Merna M. AbouKhatwa, BSc · Faculty of Pharmacy, Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-18
Primary Completion
2023-01-17
Completion
2023-04-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05599399 on ClinicalTrials.gov